• Amazon Pharmacy’s PillPack service now extends to over 50 million Medicare Part D users.
• Analysts project an average price target of $240.81 for Amazon stock, suggesting significant upside potential.
• GuruFocus estimates a GF Value of $187.83 for Amazon, indicating a possible downside from the current price.

Amazon Pharmacy has broadened its healthcare reach by introducing the PillPack service to a vast segment of over 50 million Medicare Part D participants. This service simplifies medication management by providing pre-sorted packets that are clearly marked with date and time. Furthermore, a new functionality allows caregivers to manage medications for others seamlessly through their accounts, significantly enhancing user convenience.

According to the insights gathered from 67 industry analysts, Amazon.com Inc (AMZN, Financial) has a projected average target price of $240.81 over the next year. Analysts provide a range with a high estimate of $305.00 and a low estimate of $195.00. This average target suggests an
upside of 16.48%
from the current trading price of $206.74. For more precise data, visit the Amazon.com Inc (AMZN) Forecast page.

The consensus among 73 brokerage firms rates Amazon.com Inc’s (AMZN, Financial) performance as 1.8, which aligns with an “Outperform” status. This rating operates on a scale where 1 indicates a Strong Buy and 5 signals a Sell.

From a valuation perspective, GuruFocus estimates the one-year GF Value for Amazon.com Inc (AMZN, Financial) to be $187.83. This suggests a
downside
of 9.15% from its current market price of $206.74. GF Value is determined by GuruFocus as the fair trading value of a stock, calculated by assessing historical trading multiples, past growth trajectories, and future business performance estimates. Additional details can be accessed on the Amazon.com Inc (AMZN) Summary page.